Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore S Lawrence

Showing results (31-40 of 389) with videos related to

Pageof 39
Sort By:
Seminars in Radiation Oncology|June 9, 2015
Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade GliomaMichelle M Kim, Theodore S Lawrence, Yue Cao
Cancer Journal (Sudbury, Mass.)|October 5, 2023
Evolution of Response-Based Radiotherapy for Hepatocellular CancerAmeer L Elaimy, Yue Cao, Theodore S Lawrence
Seminars in Radiation Oncology|May 26, 2009
Functional and metabolic magnetic resonance imaging and positron emission tomography for tumor volume definition in high-grade gliomasChristina I Tsien, Yue Cao, Theodore S Lawrence
Seminars in Radiation Oncology|January 10, 2003
The mechanism of action of radiosensitization of conventional chemotherapeutic agentsTheodore S Lawrence, A William Blackstock, Cornelius McGinn
Radiation Research|February 13, 2002
Wild-type TP53 inhibits G(2)-phase checkpoint abrogation and radiosensitization induced by PD0166285, a WEE1 kinase inhibitorJun Li, Yuli Wang, Yi Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2008
Radiation increases invasion of gene-modified mesenchymal stem cells into tumorsSteven P Zielske, Donna L Livant, Theodore S Lawrence
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2014
Enhancing the efficacy of radiation therapy: premises, promises, and practicalityC Norman Coleman, Theodore S Lawrence, David G Kirsch
Translational Oncology|June 22, 2010
Loss of tumor-initiating cell activity in cyclophosphamide-treated breast xenograftsSteven P Zielske, Aaron C Spalding, Theodore S Lawrence
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Milestones in the use of combined-modality radiation therapy and chemotherapyTheodore S Lawrence, Bruce G Haffty, Jay R Harris
Cancer|September 5, 2002
On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancerCornelius J McGinn, Theodore S Lawrence, Mark M Zalupski
Pageof 39

Showing results (31-40 of 389) with videos related to

Sort By:
Pageof 39
Seminars in Radiation Oncology|June 9, 2015
Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade GliomaMichelle M Kim, Theodore S Lawrence, Yue Cao
Cancer Journal (Sudbury, Mass.)|October 5, 2023
Evolution of Response-Based Radiotherapy for Hepatocellular CancerAmeer L Elaimy, Yue Cao, Theodore S Lawrence
Seminars in Radiation Oncology|May 26, 2009
Functional and metabolic magnetic resonance imaging and positron emission tomography for tumor volume definition in high-grade gliomasChristina I Tsien, Yue Cao, Theodore S Lawrence
Seminars in Radiation Oncology|January 10, 2003
The mechanism of action of radiosensitization of conventional chemotherapeutic agentsTheodore S Lawrence, A William Blackstock, Cornelius McGinn
Radiation Research|February 13, 2002
Wild-type TP53 inhibits G(2)-phase checkpoint abrogation and radiosensitization induced by PD0166285, a WEE1 kinase inhibitorJun Li, Yuli Wang, Yi Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2008
Radiation increases invasion of gene-modified mesenchymal stem cells into tumorsSteven P Zielske, Donna L Livant, Theodore S Lawrence
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2014
Enhancing the efficacy of radiation therapy: premises, promises, and practicalityC Norman Coleman, Theodore S Lawrence, David G Kirsch
Translational Oncology|June 22, 2010
Loss of tumor-initiating cell activity in cyclophosphamide-treated breast xenograftsSteven P Zielske, Aaron C Spalding, Theodore S Lawrence
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Milestones in the use of combined-modality radiation therapy and chemotherapyTheodore S Lawrence, Bruce G Haffty, Jay R Harris
Cancer|September 5, 2002
On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancerCornelius J McGinn, Theodore S Lawrence, Mark M Zalupski
Pageof 39